• About
  • Advertise
  • Careers
  • Contact
Sunday, April 11, 2021
  • Login
WRITE FOR US
Economy.pk
  • World
    • Americas
    • Asia
    • Europe
    • Canada
    • Africa
    • Middle East
    • Oceania
  • Politics
    • International Politics
    • Pakistan Politics
  • Business
    • Economy
    • Finance
    • Entrepreneurship
    • Real Estate
  • Technology
    • Cyber Security
    • Mobiles
    • Social Media
  • Sports
  • Education
  • Life & Style
    • Personalities
    • Entertainment
    • Art
    • Fashion
    • History
    • Culture
    • Health
      • Environment
      • Fitness
    • Food
  • Opinions
  • World
    • Americas
    • Asia
    • Europe
    • Canada
    • Africa
    • Middle East
    • Oceania
  • Politics
    • International Politics
    • Pakistan Politics
  • Business
    • Economy
    • Finance
    • Entrepreneurship
    • Real Estate
  • Technology
    • Cyber Security
    • Mobiles
    • Social Media
  • Sports
  • Education
  • Life & Style
    • Personalities
    • Entertainment
    • Art
    • Fashion
    • History
    • Culture
    • Health
      • Environment
      • Fitness
    • Food
  • Opinions
Economy.pk

Vaccine for COVID-19 US Deals with Sanofi & GSK in $2.1Bn

byMuhammad Abdul Wasay
8 months ago
in Americas, Health, World
0
Vaccine for COVID-19 US Deals with Sanofi & GSK in $2.1Bn
23
SHARES
488
VIEWS
Share on FacebookShare on Twitter

The US government has announced that it will pay $2.1 billion to Sanofi SA and GSK GlaxoSmithKline for making the COVID-19 vaccine, to cover 50 million people and the infected. The Drugmakers are furnished with the biggest yet from “Operation Warp Speed”, the White House initiative aimed at accelerating access to vaccines and treatments to fight Covid-19. The respiratory disease caused by the novel coronavirus.

The deal, announced by the US Department of Health and Human Services and Department of Defence, works out at a cost of around $42 per person. However, this is almost identical to the $40 per patient US agreed to pay Pfizer and BioNTech SE when it inked on nearly $2 billion deal for 50 million courses of that potential vaccine last week.

The deal is for 100 million doses two per person and gives the government an option to purchase an additional 500 million doses at an unspecified price. Sanofi and GSK plan to start clinical trials for the vaccine in September. Sanofi executive Clement Lewin said the companies have not yet agreed with on a specific price for the additional doses.

Vaccine

GSK said in a statement that, “more than half of the total funding will go into further development of the vaccine, including clinical trials, with the remainder used for a manufacturing ramp-up and delivery of the doses.”

Both the companies’ immunization is combination of a vaccine based on Sanofi’s flu shots and a complementary technology from GSK called an adjuvant, designed to improve the vaccine’s potency to heal. It marks the second contract for the Franco-British pair’s vaccine candidate after they agreed earlier this week to supply 60 million doses to the British government.

Last week Pfizer’s deal was expected to set a benchmark for future deals between the drug-makers and the government. Moderna Inc and Pfizer began with two 30,000-subject trials of Covid-19 vaccines on Monday that could clear the way for regulatory approval and use by the end of this year.

Tags: COVID-19COVID-19 VaccineGlaxoSmithKlineGSKSanofiUnited StatesUS
Muhammad Abdul Wasay

Muhammad Abdul Wasay

Next Post
Rainforest Fires in Brazil Worsening, it could further Worsen

Rainforest Fires in Brazil Worsening, it could further Worsen

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Recommended

Private missions

First-time space travelers can take part in Private Missions

My heritage

Animate photos with the Deep nostalgia tool

China

China’s Covid-19 vaccine production to hit 3 billion

Rice

China the main destination for the export of Rice

G-20

Pakistan secures another $1 billion debt relief

Prince Philip

Prince Philip, Gun Salutes planned across the UK in tribute

Connect with us

Twitter

Economy.pk

Economy.pk touches diverse topics with a lighter note and is geared toward audiences with various interests and all ages. Come and explore Economy.pk. Ample details and analysis are provided in extraordinarily readable manner making them compelling and interesting at the same time.

Category

  • World
  • Politics
  • Business
  • Technology
  • Education
  • Health
  • Life & Style
  • Opinions

Social Media

  • Facebook
  • Twitter

Sitelinks

  • Sitemap

Download our APP

download on android app download on apple app
  • About
  • Advertise
  • Careers
  • Contact

© 2020 All Rights Reserved Economy.pk

  • Finance
  • Politics
  • Business
    • Technology
    • Real Estate
    • Entrepreneurship
  • Life & Style
    • Personalities
  • Sponsored

© 2020 All Rights Reserved Economy.pk

No Result
View All Result

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In